Immunophenotyping
WikiDoc Resources for Immunophenotyping |
Articles |
---|
Most recent articles on Immunophenotyping Most cited articles on Immunophenotyping |
Media |
Powerpoint slides on Immunophenotyping |
Evidence Based Medicine |
Cochrane Collaboration on Immunophenotyping |
Clinical Trials |
Ongoing Trials on Immunophenotyping at Clinical Trials.gov Trial results on Immunophenotyping Clinical Trials on Immunophenotyping at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Immunophenotyping NICE Guidance on Immunophenotyping
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Immunophenotyping Discussion groups on Immunophenotyping Patient Handouts on Immunophenotyping Directions to Hospitals Treating Immunophenotyping Risk calculators and risk factors for Immunophenotyping
|
Healthcare Provider Resources |
Causes & Risk Factors for Immunophenotyping |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Immunophenotyping is a technique notably used in the diagnosis of leukemia. It involves the labelling of white blood cells with antibodies directed against surface proteins on their membrane. By choosing appropriate antibodies, the origin of leukemic cells can be accurately determined. The labelled cells are processed in a flow cytometer, a laser-based instrument capable of analyzing thousands of cells per second. The whole procedure can be performed on cells from the blood, bone marrow or spinal fluid in a matter of a few hours.
External links
- British Society for Haematology guidelines accessed July 31, 2006
- Immunophenotyping Lymphomas, University of Medicine & Dentistry of New Jersey
- Immunophenotyping at the US National Library of Medicine Medical Subject Headings (MeSH)